Antipsychotic medications can help a person with bipolar disorder stabilize their moods, reduce agitation, and improve ...

Bristol Myers Squibb Co. said its new schizophrenia drug is off to a better start than similar recently launched treatments, ...

Dr. Jo Howe and Professor Ian Maidment from Aston Pharmacy School have won funding for a new project to develop new ways to ...

Boehringer Ingelheim’s investigational schizophrenia candidate has failed to improve cognitive impairment or functioning in a ...

Marijuana access introduces an alternative treatment to traditional prescription medication that may provide easier access ...

AbbVie and Gilead are going back to their roots and leaning on their established areas of expertise to set themselves up for ...

In 2024, the Arizona Mad Moms “took the Capitol by storm,” passing four new Arizona laws relating to Serious Mental Illness ...

Antipsychotic drug trials that specifically address the anti-hallucinatory effectiveness of the respective drugs in representative samples are rare. The aims of the present study were to ...

In states where both medical and recreational marijuana are legal, fewer patients are filling prescriptions for medications ...

Bristol Myers Squibb (NYSE:BMY) believes Alzheimer’s is the largest market for its newly approved schizophrenia drug, Cobenfy, which it expects to eventually generate billions of dollars in revenue.

Covid symptoms have largely stayed the same over the last few years: cough, congestion, fever, a sore throat, nausea, ...